• Inhibition of the m6A reader IGF2BP2 as a strategy against T-cell acute lymphoblastic leukemia 

      Feng, Panpan; Chen, Dawei; Wang, Xia; Li, Yanxia; Li, Zhenyu; Li, Boya; Zhang, Yupeng; Li, Wei; Zhang, Jingru; Ye, Jingjing; Zhao, Baobing; Li, Jingxin; Ji, Chunyan (Peer reviewed; Journal article, 2022-08-01)
      T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignant leukemia with extremely limited treatment for relapsed patients. N6‐methyladenosine (m6A) reader insulin-like growth factor 2 mRNA-binding protein 2 ...